CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD 
Best Delta 8 THC & CBD Products to Get a Head Start on Premium Hemp Quality
GLENDALE, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- The hemp products filled with different cannabinoids have become very popular as...
Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2022 and Provides Corporate Update
ONS-5010 / LYTENAVA™ (bevacizumab-vikg) Biologics License Application (BLA) submitted to U.S. Food and Drug Administration (FDA); PDUFA date expected to...
Pyxis Oncology Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update
CAMBRIDGE, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a multi-asset multi-modality company focused on developing...
CytoDyn Announces the Addition of Leading Experts in Oncology, Infectious Diseases, and Neuroinflammation to its Scientific Board of Advisors; Dr. Jay Lalezari to Serve as Outside Scientific Advisor
VANCOUVER, Washington, May 13, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing...
NeuroPace to Present at the 2022 RBC Capital Markets Global Healthcare Conference
MOUNTAIN VIEW, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on...
Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference
SEATTLE and VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical...
Longeveron Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results
Conference call scheduled for 8:30 a.m. ET todayMIAMI, May 13, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or...
Acutus Medical completes enrollment in IDE trial with its AcQBlate® FORCE Sensing Ablation System
AcQBlate FORCE System A complete ablation system which includes the smallest footprint of any RF Generator and is comprised of...
Progressive Care to Report First Quarter Financial Results on May 17, 2022
Progressive Care Inc. Has Scheduled an Investor Conference Call for 4:30 PM ET on Tuesday, May 17, 2022 MIAMI, FL,...
Tempest Reports First Quarter 2022 Financial Results and Provides Corporate Highlights
Announced oral presentation of TPST-1120 Phase 1 monotherapy and combination therapy data at ASCOPresented positive preclinical data for TPST-1495 at...
ProSomnus® Presents Data Validating Proprietary FDA-cleared Oral Appliance Therapy Devices at 2022 American Academy of Dental Sleep Medicine Annual Meeting
Data suggest ProSomnus’s patient-preferred devices can be suitable alternative to CPAPSAN FRANCISCO, May 13, 2022 (GLOBE NEWSWIRE) -- ProSomnus, the...
SeqLL Provides First Quarter 2022 Financial Results and a Corporate Update
BILLERICA, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company...
Ocuphire Pharma Announces Financial Results for First Quarter 2022 and Provides Corporate Update
Nyxol Posts 5 Positive Clinical Data Readouts Including Presbyopia in Last 12 Months Successfully Enrolled 4 Late-Stage Trials for Nyxol...
MEDIROM Healthcare Technologies Inc. Announces Preliminary 2021 Financial Results
Revenue growth of 62% / Total Gross Margin 26.4%NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc....
Genenta to Present at Upcoming Scientific Congresses ASGCT, BTM, ASCO and EHA
MILAN, Italy and NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering...
Vitalhub Corp to Present at the Roth Canada Showcase Day
TORONTO, May 13, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) today announces that will be...
Statera Biopharma and Lay Sciences Inc. Announce Intent to Enter Strategic Partnership to License the Manufacturing Rights to Certain Lay Sciences IgY Products
Statera expects to acquire option to license Lay Sciences products for respiratory & gastrointestinal disordersFORT COLLINS, Colo., May 13, 2022...
LifeMD, Inc. Reports First Quarter 2022 Results
First quarter 2022 consolidated revenue of $29.0 million up 60% from the same year ago period.Adjusted EPS of $(0.25), 14%...
InMed Pharmaceuticals Reports Third Quarter Fiscal 2022 Financial Results and Provides Business Update
Expands rare cannabinoid portfolio with the addition of CBT and CBDVStrengthens IP with publication of a patent application for novel...
BridgeBio Pharma Sells Rare Pediatric Disease Priority Review Voucher for $110 Million and Defers Principal Payment on Senior Debt by Two Years
-Entered into a definitive agreement to sell the rare pediatric disease Priority Review Voucher (PRV) it obtained in February 2021...